Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients ; volume:3 ; number:1 ; day:15 ; month:2 ; year:2023 ; pages:1-9 ; date:12.2023
Communications medicine ; 3, Heft 1 (15.2.2023), 1-9, 12.2023
- Urheber
-
Nuzzo, Tommaso
Russo, Rosita
Errico, Francesco
D’Amico, Adele
Tewelde, Awet G.
Valletta, Mariangela
Hassan, Amber
Tosi, Michele
Panicucci, Chiara
Bruno, Claudio
Bertini, Enrico
Chambery, Angela
Pellizzoni, Livio
Usiello, Alessandro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s43856-023-00256-2
- URN
-
urn:nbn:de:101:1-2023120808465220232622
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nuzzo, Tommaso
- Russo, Rosita
- Errico, Francesco
- D’Amico, Adele
- Tewelde, Awet G.
- Valletta, Mariangela
- Hassan, Amber
- Tosi, Michele
- Panicucci, Chiara
- Bruno, Claudio
- Bertini, Enrico
- Chambery, Angela
- Pellizzoni, Livio
- Usiello, Alessandro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US
Observations on spinal muscular atrophy in context of treatment with Nusinersen : a neuropsychological approach
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US
Observations on spinal muscular atrophy in context of treatment with Nusinersen : a neuropsychological approach
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US